2042-0064

Journal of Osteoporosis

Hindawi Limited

View prefix report (10.1155)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 87 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact87 DOIs
2

Add abstracts to 16 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact16 DOIs
3

Deposit reference lists for 7 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 177 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Normocalcemic versus Hypercalcemic Primary Hyperparathyroidi… (10.1155/2012/128352)
Abstract ORCID
90.65 64
2 Osteoporosis in Men (10.1155/2012/675984)
Abstract ORCID
62.76 17
3 New and Emerging Therapies for Osteoporosis (10.4061/2010/318320)
Abstract References ORCID
52.42 4
4 Secondary Osteoporosis: Endocrine and Metabolic Causes of Bo… (10.1155/2012/907214)
Abstract ORCID
47.71 8
5 Progesterone and Bone: Actions Promoting Bone Health in Wome… (10.4061/2010/845180)
ORCID
47.44 78
6 A Study of Bone Mineral Density and Its Determinants in Type… (10.1155/2013/397814)
ORCID
45.49 65
7 Bone Density and Cortical Thickness in Normal, Osteopenic, a… (10.4061/2010/504078)
ORCID
45.32 64
8 Geographic Variation in Osteoporotic Hip Fracture Incidence:… (10.4061/2010/757102)
ORCID
42.90 51
9 Scientific Basis for the Potential Use of Melatonin in Bone… (10.4061/2010/830231)
ORCID
42.90 51
10 Sclerostin Antibody Therapy for the Treatment of Osteoporosi… (10.1155/2016/6217286)
ORCID
42.69 50
11 Osteoporosis Syndrome in Thalassaemia Major: An Overview (10.4061/2010/537673)
ORCID
41.09 43
12 Dropouts and Compliance in Exercise Interventions Targeting… (10.1155/2013/250423)
Abstract
40.05 39
13 Nanohydroxyapatite Application to Osteoporosis Management (10.1155/2013/679025)
ORCID
39.49 37
14 Association of MRS-Based Vertebral Bone Marrow Fat Fraction… (10.1155/2015/152349)
ORCID
39.49 37
15 Osteoporosis in Healthy South Indian Males and the Influence… (10.1155/2014/723238)
ORCID
38.29 33
16 Inhibition of Bone Loss by<i>Cissus quadrangularis</i>in Mic… (10.1155/2012/101206)
ORCID
37.63 31
17 Sex- and Age-Related Differences in Bone Microarchitecture i… (10.1155/2012/129760)
ORCID
37.28 30
18 Modulating P2X7 Receptor Signaling during Rheumatoid Arthrit… (10.1155/2012/408242)
ORCID
37.28 30
19 P2X7 Receptor Function in Bone-Related Cancer (10.1155/2012/637863)
ORCID
37.28 30
20 Normative Data for Bone Mass in Healthy Term Infants from Bi… (10.1155/2012/672403)
ORCID
37.28 30
21 Superparamagnetic Bifunctional Bisphosphonates Nanoparticles… (10.4061/2010/747852)
ORCID
37.28 30
22 Knowledge, Health Beliefs, and Self-Efficacy regarding Osteo… (10.1155/2013/853531)
ORCID
36.93 29
23 The Significance of Soy Protein and Soy Bioactive Compounds… (10.4061/2010/891058)
ORCID
36.93 29
24 Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiv… (10.1155/2015/627631)
ORCID
36.56 28
25 Sclerostin (10.4061/2010/941419)
ORCID
36.56 28
26 Surgical Approach and Laser Applications in BRONJ Osteoporot… (10.1155/2012/585434)
ORCID
36.18 27
27 Serum Dickkopf-1 Level in Postmenopausal Females: Correlatio… (10.1155/2013/460210)
ORCID
36.18 27
28 Does Percutaneous Kyphoplasty Have Better Functional Outcome… (10.1155/2013/690329)
ORCID
36.18 27
29 Effects of Vitamin E on Bone Biomechanical and Histomorphome… (10.1155/2013/825985)
ORCID
36.18 27
30 SOST and DKK: Antagonists of LRP Family Signaling as Targets… (10.4061/2010/460120)
ORCID
35.78 26
31 Genetic Background Strongly Influences the Bone Phenotype of… (10.1155/2012/391097)
ORCID
34.95 24
32 High Folic Acid Intake during Pregnancy Lowers Body Weight a… (10.1155/2013/154109)
ORCID
34.51 23
33 Odanacatib, a New Drug for the Treatment of Osteoporosis: Re… (10.4061/2010/401581)
ORCID
34.51 23
34 Whole-Body versus Local DXA-Scan for the Diagnosis of Osteop… (10.4061/2010/640878)
ORCID
34.04 22
35 Survivorship and Severe Complications Are Worse for Octogena… (10.1155/2012/475739)
ORCID
33.56 21
36 PTH Assays: Understanding What We Have and Forecasting What… (10.1155/2012/523246)
ORCID
33.06 20
37 Total Parathyroidectomy with Presternal Intramuscular Autotr… (10.1155/2012/631243)
ORCID
33.06 20
38 Bone Mineral Density and Body Composition of Adult Premenopa… (10.1155/2013/953271)
ORCID
33.06 20
39 Incidence of Fractures after Cardiac and Lung Transplantatio… (10.1155/2014/573041)
ORCID
33.06 20
40 Cross-Calibration of GE Healthcare Lunar Prodigy and iDXA Du… (10.1155/2016/1424582)
ORCID
33.06 20
41 Adherence and Persistence with Once-Daily Teriparatide in Ja… (10.1155/2013/654218)
ORCID
32.53 19
42 Black Tea May Be a Prospective Adjunct for Calcium Supplemen… (10.1155/2013/760586)
ORCID
32.53 19
43 Effects of Whole Body Vibration and Resistance Training on B… (10.1155/2014/702589)
ORCID
32.53 19
44 Bone Mineral Density in Spinal Cord Injury: An Evaluation of… (10.1155/2012/519754)
ORCID
31.97 18
45 Association between P2X7 Receptor Polymorphisms and Bone Sta… (10.1155/2012/637986)
ORCID
31.97 18
46 The Most Cited Papers in Osteoporosis and Related Research (10.1155/2015/638934)
ORCID
31.97 18
47 Are Selective Serotonin Reuptake Inhibitors a Secondary Caus… (10.1155/2012/323061)
ORCID
31.38 17
48 Purinergic Signaling in Bone (10.1155/2013/673684)
Abstract References
30.10 3
49 Changes in Dickkopf-1 (<i>DKK1</i>) and Sclerostin following… (10.1155/2014/682763)
ORCID
30.10 15
50 Corrigendum to “Potential Extensions of the US FRAX Algorith… (10.1155/2018/3021801)
Abstract ORCID
30.10 3